December 04, 2017
Biophytis has FAMHP Approval to conduct SARA-INT phase 2b Interventional Study of Sarconeos in Sarcopenia in Belgium. Read the Press Release
November 01, 2017
Biophytis completes a € 7,5 M capital increase to help accelerate pipeline programs in orphan pediatric diseases. Read the press release
October 30, 2017
Biophytis has FDA Approval to initiate SARA-INT phase 2b Interventional Study of Sarconeos in Sarcopenia. Read the Press Release
October 27, 2017
Biophytis appoints Professor Thomas Voit to Scientific Advisory Board to help accelerate pipeline programs in orphan pediatric diseases. Read the Press Release
October 26, 2017
Half-Year Financial Report as of June 30, 2017. Read the press release
17 october 2017
Biophytis will present at the Galien MedStartUp Partnering Day on October 26, 2017 in New York
October 11, 2017
Biophytis completes a €10.4 M capital increase to finance mid-stage clinical trials for two novel anti-aging drug-candidates. Read the Press Release
October 10, 2017
Interview of Stanislas Veillet, CEO of Biophytis for the European Large & Midcap event 2017 with Didier Testot, journalist on the Web tv www.labourseetlavie.com
September 2, 2017
Biophytis filed IND application for approval by FDA of SARA-INT Phase 2b study of Sarconeos in Sarcopenia. Read the Press Release
September 20, 2017
Biophytis to participate in upcoming industry and investors conferences. Read the Press Release